TMEM106B, a risk factor for FTLD and aging, has an intrinsically disordered cytoplasmic domain.
TMEM106B was initially identified as a risk factor for FTLD, but recent studies highlighted its general role in neurodegenerative diseases. Very recently TMEM106B has also been characterized to regulate aging phenotypes. TMEM106B is a 274-residue lysosomal protein whose cytoplasmic domain functions...
Main Authors: | Jian Kang, Liangzhong Lim, Jianxing Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6192649?pdf=render |
Similar Items
-
The FTLD risk factor TMEM106B controls lysosomal trafficking and dendrite outgrowth
by: Schwenk, Benjamin
Published: (2015) -
The FTLD Risk Factor TMEM106B Regulates the Transport of Lysosomes at the Axon Initial Segment of Motoneurons
by: Patrick Lüningschrör, et al.
Published: (2020-03-01) -
A unified mechanism for LLPS of ALS/FTLD-causing FUS as well as its modulation by ATP and oligonucleic acids.
by: Jian Kang, et al.
Published: (2019-06-01) -
Variation in TMEM106B in chronic traumatic encephalopathy
by: Jonathan D. Cherry, et al.
Published: (2018-11-01) -
ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.
by: Liangzhong Lim, et al.
Published: (2016-01-01)